5 Einträge gefunden

1. Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy

   1. Laukhtina, Ekaterina
   2. Quhal, Fahad
   3. Mori, Keiichiro
   4. Sari Motlagh, Reza
   5. Rajwa, Pawel
   6. Yanagisawa, Takafumi
   7. Mostafaei, Hadi

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review

   1. Laukhtina, Ekaterina
   2. Pradere, Benjamin
   3. Mori, Keiichiro
   4. Schuettfort, Victor M
   5. Quhal, Fahad
   6. Mostafaei, Hadi
   7. Sari Motlagh, Reza

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis

   1. Laukhtina, Ekaterina
   2. Mori, Keiichiro
   3. Mostafaei, Hadi
   4. Merseburger, Axel S
   5. Nyirady, Peter
   6. Moschini, Marco
   7. Quhal, Fahad

   2021 - Forschungsinformationssystem des UKE
4. Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review

   1. Laukhtina, Ekaterina
   2. Pradere, Benjamin
   3. Mori, Keiichiro
   4. Schuettfort, Victor M
   5. Quhal, Fahad
   6. Mostafaei, Hadi
   7. Sari Motlangh, Reza

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer

   1. Quhal, Fahad
   2. Pradere, Benjamin
   3. Laukhtina, Ekaterina
   4. Sari Motlagh, Reza
   5. Mostafaei, Hadi
   6. Mori, Keiichiro
   7. Schuettfort, Victor M

   2021 - Forschungsinformationssystem des UKE - frei zugänglich